In the present study, we performed a randomized controlled trial to evaluate whether omeprazole treatment could alter the circulating and cord blood levels of sFlt-1, PlGF and CT-proET-1 (C-terminal pro-endothelin-1; a stable surrogate marker of ET-18) in women with confirmed preeclampsia. This evidence concerns the gene PGF and preeclampsia.